文献速递肝病

药物性肝损伤患者磁共振胆管成像上的硬化性胆管炎样改变

Sclerosing Cholangitis-Like Changes on Magnetic Resonance Cholangiography in Patients With Drug Induced Liver Injury.
PubMed 文献 · Clin Gastroenterol Hepatol · 2018-06-30

药物性肝损伤(DILI)可导致胆道树出现类似硬化性胆管炎的影像学改变,磁共振胰胆管成像可见。本研究旨在识别美国药物性肝损伤网络(DILIN)前瞻性研究中MRCP上出现硬化性胆管炎样改变患者的临床特征。

要点

  • 药物性肝损伤可导致磁共振胰胆管成像上出现类似硬化性胆管炎的胆道改变。
  • 既往一项25例连续非选择性DILI患者研究发现10%在MRCP上有硬化性胆管炎样改变。
  • 本研究旨在识别DILIN前瞻性研究中MRCP出现硬化性胆管炎样改变患者的临床特征。

核心结论

  • 药物性肝损伤可导致磁共振胆管成像上出现类似硬化性胆管炎的胆道改变。
  • 本研究旨在识别美国药物性肝损伤网络前瞻性研究中MRCP出现硬化性胆管炎样改变患者的临床特征。

研究设计与样本

  • 研究基于美国药物性肝损伤网络(DILIN)前瞻性研究,旨在识别MRCP上出现硬化性胆管炎样改变患者的临床特征。

主要发现

  • 既往一项25例连续非选择性DILI患者研究发现10%在磁共振胰胆管成像上有硬化性胆管炎样改变。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Drug-induced liver injury can lead to changes of the biliary tree that resemble sclerosing cholangitis. These changes can be seen on magnetic resonance cholangiopancreatography. Idiosyncratic drug-induced liver injury (DILI) has a variable presentation including cholestatic liver injury,1 in which case magnetic resonance imaging (MRI) is often performed to exclude pancreaticobiliary causes of obstruction. Sclerosing cholangitis (SC)-like changes on imaging have been described anecdotally with DILI.2,3 A recent study of 25 consecutive, unselected DILI patients found that 10% had SC-like changes on magnetic resonance cholangiopancreatography (MRCP).4 The aim of the current study was to identify the clinical features of patients enrolled in the U.S. Drug Induced Liver Injury Network (DILIN) prospective study who had SC-like changes on MRCP.

来源:Clin Gastroenterol Hepatol,查看原文。版权归原作者所有。

引用

  1. Ahmad J, Rossi S, Rodgers SK, et al. Sclerosing Cholangitis-Like Changes on Magnetic Resonance Cholangiography in Patients With Drug Induced Liver Injury. Clin Gastroenterol Hepatol. 2018. PMID: 29966706. doi:10.1016/j.cgh.2018.06.035

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。